Breztri aerosphere inhaler 10.7GM
Ended Awarded
- Contract number
- SPE2DB26FPLJW
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,931
Award facts
- Contract value 100% obligated
- $5,931.06 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp was awarded a $5,931.06 delivery order by the Defense Logistics Agency on October 27, 2025, for the supply of Breztri Aerosphere Inhaler 10.7GM. The contract is structured as a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. Performance will be fulfilled at the company's facility in Conshohocken, Pennsylvania, with an ultimate completion date of October 28, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion prime vendor agreement valued through December 2026 that provides comprehensive pharmaceutical and medical supply support to military healthcare systems worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company maintains an extensive portfolio of federal contracts with the DLA covering a wide range of pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical devices. The current delivery order for Breztri Aerosphere Inhaler—a maintenance medication used in chronic obstructive pulmonary disease treatment—demonstrates the company's ongoing role in supplying respiratory and specialty pharmaceutical products to support military and veteran healthcare needs.
Quick answers
Who was awarded contract SPE2DB26FPLJW?
SPE2DB26FPLJW was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 27, 2025.
How much is contract SPE2DB26FPLJW worth?
The government has obligated $5,931 on SPE2DB26FPLJW.
Is contract SPE2DB26FPLJW an order under another contract?
Yes. SPE2DB26FPLJW is a delivery order under SPE2DB20D2001, an indefinite delivery contract.
Was contract SPE2DB26FPLJW competed?
The extent of competition for SPE2DB26FPLJW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award